12/19/2024
3:11 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2024
5:04 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
3:31 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
8:49 PM | BB BIOTECH AG (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A | |
11/18/2024
8:12 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
5:05 AM | Molecular Templates (Filer)
| Form NT 10-Q | |
11/12/2024
8:31 AM | Adage Capital Management, L.P. (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A | |
|
10/28/2024
4:20 PM | Molecular Templates (Filer)
| Form DEF 14A | |
10/17/2024
4:05 PM | Molecular Templates (Filer)
| Form PRE 14A | |
10/11/2024
3:39 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
3:02 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
4:35 PM | Molecular Templates (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:36 PM | HOFFMANN DAVE (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:36 PM | Molecular Templates (Issuer)
SELICK HAROLD E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:37 PM | Gruia Gabriela (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:41 PM | LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:01 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
3:36 PM | Molecular Templates (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
3:26 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:43 PM | Molecular Templates (Filer)
| Form DEF 14A | |
08/13/2024
3:44 PM | Molecular Templates (Filer)
| Form DEFA14A | |
08/13/2024
3:47 PM | Molecular Templates (Filer)
| Form ARS | |
06/03/2024
7:13 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
4:18 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
4:21 PM | Molecular Templates (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2024
11:15 PM | Molecular Templates (Filer)
| Form EFFECT | |
04/29/2024
8:51 PM | Longitude Capital Partners III, LLC (Filed by)
Molecular Templates (Subject)
| Form SC 13D/A | |
04/25/2024
3:33 PM | Molecular Templates (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/12/2024
3:22 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
7:13 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:57 PM | LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
8:56 PM | Molecular Templates (Subject)
SANTE HEALTH VENTURES I LP (Filed by)
| Form SC 13D/A | |
03/29/2024
3:06 PM | Molecular Templates (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/29/2024
7:57 AM | Molecular Templates (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/29/2024
7:45 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
7:22 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:08 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:39 PM | Molecular Templates (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
02/14/2024
3:45 PM | K2 HealthVentures Equity Trust LLC (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A | |
02/14/2024
8:33 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A | |
02/13/2024
10:00 AM | BB BIOTECH AG (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A | |
Vladimir Lenin was right… (Ad) The Magnificent 7 could be in for a world of pain…
And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock.
The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on.
It’s called The Final Frontier. Including the name of the #1 company to buy. |
01/25/2024
4:32 PM | Molecular Templates (Issuer)
Poma Eric E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
4:34 PM | Kim Jason S. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
4:49 PM | Molecular Templates (Issuer)
Voi Maurizio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
